Pages with the most revisions

From OncoWiki

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. EPOCH-DA‏‎ (16 revisions)
  2. Main Page‏‎ (11 revisions)
  3. Adrenocortical Carcinoma‏‎ (11 revisions)
  4. Acute Myeloid Leukemia,Adult‏‎ (10 revisions)
  5. Stem Cell Transplantation‏‎ (8 revisions)
  6. Lymphoma Non-Hodgkin's, Adult‏‎ (6 revisions)
  7. Multiple Myeloma And Plasma Cell Dyscrasias‏‎ (6 revisions)
  8. Lymphoma Hodgkin's, Adult‏‎ (5 revisions)
  9. Cyclophosphamide Bortezomib Dexamethasone‏‎ (4 revisions)
  10. Cytotoxic Regimens‏‎ (4 revisions)
  11. CLAG-M‏‎ (4 revisions)
  12. BEAM‏‎ (4 revisions)
  13. Cancer treatment information‏‎ (3 revisions)
  14. Guidelines for contributors‏‎ (3 revisions)
  15. FOLFIRINOX‏‎ (3 revisions)
  16. APL4 - ALLG‏‎ (3 revisions)
  17. Pancreatic Cancer‏‎ (3 revisions)
  18. SMILE‏‎ (3 revisions)
  19. Brentuximab vedotin‏‎ (3 revisions)
  20. ATRA plus As203‏‎ (3 revisions)
  21. Clofarabine, cyclophosphamide and etoposide‏‎ (3 revisions)
  22. Standard BEACOPP‏‎ (2 revisions)
  23. Ifosfamide‏‎ (2 revisions)
  24. Dexamethosone‏‎ (2 revisions)
  25. CEOP‏‎ (2 revisions)
  26. Thal/Dex‏‎ (2 revisions)
  27. Endometrial Cancer‏‎ (2 revisions)
  28. MiCMA‏‎ (2 revisions)
  29. FOLFIRI + Bevacizumab‏‎ (2 revisions)
  30. Cervical Cancer‏‎ (2 revisions)
  31. 5-FU + RT‏‎ (2 revisions)
  32. Flu Bu ATG - Slavin‏‎ (2 revisions)
  33. Paclitaxel‏‎ (2 revisions)
  34. GEM-Vinorelbine-Pred‏‎ (2 revisions)
  35. Cisplatin + Etoposide + Bleomycin‏‎ (2 revisions)
  36. R-FCM‏‎ (2 revisions)
  37. Goserelin + Flutamide + RT‏‎ (2 revisions)
  38. Cyclophosphamide‏‎ (2 revisions)
  39. Bevacizumab + Erlotinib‏‎ (2 revisions)
  40. Stanford V‏‎ (2 revisions)
  41. Ifosfamide + Paclitaxel‏‎ (2 revisions)
  42. Docetaxel‏‎ (2 revisions)
  43. CEP‏‎ (2 revisions)
  44. Thymoma And Thymic Carcinoma‏‎ (2 revisions)
  45. M-BACOD‏‎ (2 revisions)
  46. Erlotinib‏‎ (2 revisions)
  47. CapIri‏‎ (2 revisions)
  48. VMP‏‎ (2 revisions)
  49. Mini-BEAM‏‎ (2 revisions)
  50. FOLFIRI + Cetuximab‏‎ (2 revisions)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)